Pirfenidone inhibits TGF-β expression in malignant glioma cells
- 10 January 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 354 (2), 542-547
- https://doi.org/10.1016/j.bbrc.2007.01.012
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Smad-Sp1 complexes mediate TGF -induced early transcription of oncogenic Smad7 in pancreatic cancer cellsCarcinogenesis: Integrative Cancer Research, 2006
- Proteolytic activation of latent TGF‐β precedes caspase‐3 activation and enhances apoptotic death of lung epithelial cellsJournal of Cellular Physiology, 2006
- SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma CellsIn vitroandIn vivoCancer Research, 2004
- RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates TumorigenicityIn vivoCancer Research, 2004
- Extraembryonic proteases regulate Nodal signalling during gastrulationNature, 2002
- Mechanism of Transforming Growth Factor β–induced Inhibition of T Helper Type 1 DifferentiationThe Journal of Experimental Medicine, 2002
- Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic ratsBritish Journal of Pharmacology, 2001
- Transforming Growth Factors β1 (TGF-β1) and TGF-β2 Promote Glioma Cell Migration via Up-Regulation of αVβ3 Integrin ExpressionBiochemical and Biophysical Research Communications, 2000
- The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-β, T-cell apoptosis, and the immune privilege of the brainBrain Research Reviews, 1995
- Furin-dependent intracellular activation of the human stromelysin-3 zymogenNature, 1995